Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
ATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGC| |GCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCAT
End
58624654/58397519 (Hg38)
Nearest miRNA
hsa-mir-1301/Upstream/2396724; hsa-mir-10b/Downstream/1989843;
Upstream sequence
AGGTATCCTAACTTACCCTTCTTCTGAAAGCAACTAAATGCTAAGCAATTCTTTTTTAACTCCTTAAGTGCATTAATAATATGACTACAAGACAAATAAA
Downstream sequence
AAACTAAGTGAAGTCAAGATTCCAGAAGTGTTTCTATGTAAGAGAATAAGAGTAAGTTAGAAACAAGCCAGATTCCTTCCTCCCTGCACCCCACATTCCA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.